Gene Editing as a Therapeutic Approach for Rett Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Gene Editing as a Therapeutic Approach for Rett Syndrome — Stella

Recruiting

Back to Rett Syndrome trials

Trial locations(1 site)

Italy

University of Siena, Siena, Siena

Key details

Sponsor

University of Siena

Enrollment target

~40 participants

Started

March 2021

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

6 Months and older

Sex

Female only

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov